GREGORY IAN FROST Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY IAN FROST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY IAN FROST. GREGORY IAN FROST is VP and Chief Scientific Off. in HALOZYME THERAPEUTICS INC ($GYHT).
GREGORY IAN FROST in HALOZYME THERAPEUTICS, INC.
Trading Symbol: GYHTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GREGORY IAN FROST: VP and Chief Scientific Off.
Holdings: 3,069,606 shares
Latest Transaction: Oct 26 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY IAN FROST in HALOZYME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,754 | 6,774 | 814,954 | |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.20 | 275 | 2,530 | 3,069,606 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.18 | 400 | 3,672 | 3,069,881 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.17 | 200 | 1,834 | 3,070,281 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.16 | 25 | 229 | 3,070,481 | 3.1 M to 3.1 M (0.00 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.15 | 800 | 7,320 | 3,070,506 | 3.1 M to 3.1 M (-0.03 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.14 | 800 | 7,312 | 3,071,306 | 3.1 M to 3.1 M (-0.03 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.13 | 400 | 3,652 | 3,072,106 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 100 | 912 | 3,072,506 | 3.1 M to 3.1 M (0.00 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.11 | 300 | 2,733 | 3,072,606 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.09 | 600 | 5,454 | 3,072,906 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.08 | 600 | 5,448 | 3,073,506 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.07 | 100 | 907 | 3,074,106 | 3.1 M to 3.1 M (0.00 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.06 | 200 | 1,812 | 3,074,206 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.05 | 400 | 3,620 | 3,074,406 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.04 | 900 | 8,136 | 3,074,806 | 3.1 M to 3.1 M (-0.03 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.03 | 200 | 1,806 | 3,075,706 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.02 | 1,100 | 9,922 | 3,075,906 | 3.1 M to 3.1 M (-0.04 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.01 | 200 | 1,802 | 3,077,006 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.00 | 46 | 414 | 3,077,206 | 3.1 M to 3.1 M (0.00 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.99 | 600 | 5,394 | 3,077,252 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 1,354 | 12,159 | 3,077,852 | 3.1 M to 3.1 M (-0.04 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.97 | 700 | 6,279 | 3,079,206 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.96 | 700 | 6,272 | 3,079,906 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 1,900 | 17,005 | 3,080,606 | 3.1 M to 3.1 M (-0.06 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.94 | 1,100 | 9,834 | 3,082,506 | 3.1 M to 3.1 M (-0.04 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.93 | 300 | 2,679 | 3,083,606 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.92 | 300 | 2,676 | 3,083,906 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.91 | 400 | 3,564 | 3,084,206 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.98 | 754 | 6,771 | 3,084,606 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,754 | 6,774 | 3,085,360 | 3.1 M to 3.1 M (+0.51 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,747 | 6,771 | 830,708 | |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 200 | 1,824 | 3,069,606 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.11 | 500 | 4,555 | 3,069,806 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.10 | 400 | 3,640 | 3,070,306 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.09 | 500 | 4,545 | 3,070,706 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.04 | 600 | 5,424 | 3,071,206 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.02 | 1,500 | 13,530 | 3,071,806 | 3.1 M to 3.1 M (-0.05 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.01 | 400 | 3,604 | 3,073,306 | 3.1 M to 3.1 M (-0.01 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.00 | 900 | 8,100 | 3,073,706 | 3.1 M to 3.1 M (-0.03 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.99 | 760 | 6,832 | 3,074,606 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 500 | 4,490 | 3,075,366 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.97 | 1,600 | 14,352 | 3,075,866 | 3.1 M to 3.1 M (-0.05 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.96 | 3,040 | 27,238 | 3,077,466 | 3.1 M to 3.1 M (-0.10 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 1,500 | 13,425 | 3,080,506 | 3.1 M to 3.1 M (-0.05 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.94 | 556 | 4,971 | 3,082,006 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.93 | 500 | 4,465 | 3,082,562 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.92 | 854 | 7,618 | 3,083,062 | 3.1 M to 3.1 M (-0.03 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.91 | 690 | 6,148 | 3,083,916 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 9.06 | 747 | 6,768 | 3,084,606 | 3.1 M to 3.1 M (-0.02 %) |
Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,747 | 6,771 | 3,085,353 | 3.1 M to 3.1 M (+0.51 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 52,602 | 22,619 | 846,455 | |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.69 | 2,602 | 22,611 | 3,069,606 | 3.1 M to 3.1 M (-0.08 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 52,602 | 22,619 | 3,072,208 | 3 M to 3.1 M (+1.74 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,757 | 6,776 | 899,057 | |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.23 | 400 | 3,692 | 3,019,606 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.20 | 255 | 2,346 | 3,020,006 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.19 | 100 | 919 | 3,020,261 | 3 M to 3 M (0.00 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.16 | 100 | 916 | 3,020,361 | 3 M to 3 M (0.00 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.15 | 445 | 4,072 | 3,020,461 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 300 | 2,736 | 3,020,906 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.09 | 200 | 1,818 | 3,021,206 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.08 | 400 | 3,632 | 3,021,406 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.06 | 200 | 1,812 | 3,021,806 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.05 | 200 | 1,810 | 3,022,006 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 200 | 1,796 | 3,022,206 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 400 | 3,580 | 3,022,406 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.92 | 229 | 2,043 | 3,022,806 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.91 | 300 | 2,673 | 3,023,035 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.90 | 800 | 7,120 | 3,023,335 | 3 M to 3 M (-0.03 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.89 | 800 | 7,112 | 3,024,135 | 3 M to 3 M (-0.03 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.88 | 1,171 | 10,398 | 3,024,935 | 3 M to 3 M (-0.04 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.87 | 1,200 | 10,644 | 3,026,106 | 3 M to 3 M (-0.04 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.86 | 2,100 | 18,606 | 3,027,306 | 3 M to 3 M (-0.07 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.85 | 700 | 6,195 | 3,029,406 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.84 | 100 | 884 | 3,030,106 | 3 M to 3 M (0.00 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.83 | 1,400 | 12,362 | 3,030,206 | 3 M to 3 M (-0.05 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.82 | 1,200 | 10,584 | 3,031,606 | 3 M to 3 M (-0.04 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.81 | 500 | 4,405 | 3,032,806 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.80 | 100 | 880 | 3,033,306 | 3 M to 3 M (0.00 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.79 | 300 | 2,637 | 3,033,406 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.77 | 700 | 6,139 | 3,033,706 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.76 | 200 | 1,752 | 3,034,406 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.95 | 757 | 6,775 | 3,034,606 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,757 | 6,776 | 3,035,363 | 3 M to 3 M (+0.52 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,746 | 6,771 | 914,814 | |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.23 | 300 | 2,769 | 3,019,606 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.22 | 200 | 1,844 | 3,019,906 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.21 | 600 | 5,526 | 3,020,106 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.17 | 500 | 4,585 | 3,020,706 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.16 | 300 | 2,748 | 3,021,206 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.15 | 300 | 2,745 | 3,021,506 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.14 | 300 | 2,742 | 3,021,806 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 1,600 | 14,592 | 3,022,106 | 3 M to 3 M (-0.05 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.11 | 400 | 3,644 | 3,023,706 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.10 | 400 | 3,640 | 3,024,106 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.08 | 700 | 6,356 | 3,024,506 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.07 | 700 | 6,349 | 3,025,206 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.06 | 1,090 | 9,875 | 3,025,906 | 3 M to 3 M (-0.04 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.04 | 410 | 3,706 | 3,026,996 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.02 | 900 | 8,118 | 3,027,406 | 3 M to 3 M (-0.03 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.01 | 2,200 | 19,822 | 3,028,306 | 3 M to 3 M (-0.07 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.00 | 1,400 | 12,600 | 3,030,506 | 3 M to 3 M (-0.05 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.99 | 400 | 3,596 | 3,031,906 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 500 | 4,490 | 3,032,306 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.97 | 400 | 3,588 | 3,032,806 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.96 | 400 | 3,584 | 3,033,206 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 700 | 6,265 | 3,033,606 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.93 | 300 | 2,679 | 3,034,306 | 3 M to 3 M (-0.01 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 9.07 | 746 | 6,766 | 3,034,606 | 3 M to 3 M (-0.02 %) |
Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,746 | 6,771 | 3,035,352 | 3 M to 3 M (+0.52 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,815 | 6,800 | 930,560 | |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.59 | 100 | 859 | 3,019,606 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.58 | 200 | 1,716 | 3,019,706 | 3 M to 3 M (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.57 | 479 | 4,105 | 3,019,906 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.54 | 100 | 854 | 3,020,385 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.53 | 100 | 853 | 3,020,485 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.51 | 100 | 851 | 3,020,585 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.50 | 1,600 | 13,600 | 3,020,685 | 3 M to 3 M (-0.05 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.49 | 2,800 | 23,772 | 3,022,285 | 3 M to 3 M (-0.09 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.48 | 800 | 6,784 | 3,025,085 | 3 M to 3 M (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.47 | 300 | 2,541 | 3,025,885 | 3 M to 3 M (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.46 | 1,321 | 11,176 | 3,026,185 | 3 M to 3 M (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.45 | 500 | 4,225 | 3,027,506 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.44 | 100 | 844 | 3,028,006 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.43 | 710 | 5,985 | 3,028,106 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.42 | 990 | 8,336 | 3,028,816 | 3 M to 3 M (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.41 | 675 | 5,677 | 3,029,806 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.40 | 1,325 | 11,130 | 3,030,481 | 3 M to 3 M (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.39 | 200 | 1,678 | 3,031,806 | 3 M to 3 M (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.38 | 1,200 | 10,056 | 3,032,006 | 3 M to 3 M (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.37 | 900 | 7,533 | 3,033,206 | 3 M to 3 M (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.36 | 300 | 2,508 | 3,034,106 | 3 M to 3 M (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.35 | 100 | 835 | 3,034,406 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.34 | 100 | 834 | 3,034,506 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.34 | 815 | 6,797 | 3,034,606 | 3 M to 3 M (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,815 | 6,800 | 3,035,421 | 3 M to 3 M (+0.52 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,801 | 6,794 | 946,375 | |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.45 | 100 | 845 | 3,019,606 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.44 | 500 | 4,220 | 3,019,706 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.43 | 100 | 843 | 3,020,206 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.42 | 900 | 7,578 | 3,020,306 | 3 M to 3 M (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.41 | 600 | 5,046 | 3,021,206 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.40 | 100 | 840 | 3,021,806 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.39 | 100 | 839 | 3,021,906 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.38 | 600 | 5,028 | 3,022,006 | 3 M to 3 M (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.37 | 100 | 837 | 3,022,606 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.36 | 28 | 234 | 3,022,706 | 3 M to 3 M (0.00 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.35 | 772 | 6,446 | 3,022,734 | 3 M to 3 M (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.31 | 1,300 | 10,803 | 3,023,506 | 3 M to 3 M (-0.04 %) |